Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAYTRANA: 1,448 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
1,448
Total FAERS Reports
1 (0.1%)
Deaths Reported
2
Hospitalizations
1,448
As Primary/Secondary Suspect
1
Disabilities

First Report: 1930 · Latest Report: 20140403

What Are the Most Common DAYTRANA Side Effects?

#1 Most Reported
Product quality issue
747 reports (51.6%)
#2 Most Reported
No adverse event
580 reports (40.1%)
#3 Most Reported
Wrong technique in drug usage process
376 reports (26.0%)

All DAYTRANA Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Product quality issue 747 51.6% 0 0
No adverse event 580 40.1% 0 0
Wrong technique in drug usage process 376 26.0% 0 0
Off label use 306 21.1% 0 0
Incorrect drug administration duration 287 19.8% 0 0
Application site erythema 263 18.2% 0 0
Drug prescribing error 240 16.6% 0 0
Drug administration error 204 14.1% 0 0
Drug ineffective 182 12.6% 0 0
Drug administered at inappropriate site 141 9.7% 0 0
Application site pruritus 122 8.4% 0 0
Drug dose omission 114 7.9% 0 0
Application site irritation 100 6.9% 0 0
Disturbance in social behaviour 89 6.2% 0 0
Disturbance in attention 87 6.0% 0 0
Decreased appetite 62 4.3% 0 0
Application site pain 53 3.7% 0 0
Psychomotor hyperactivity 45 3.1% 0 0
Application site rash 42 2.9% 0 0
Insomnia 29 2.0% 0 0

Who Reports DAYTRANA Side Effects? Age & Gender Data

Average age: 11.7 years. Most reports from: US. View detailed demographics →

Is DAYTRANA Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2006 1 0 0
2008 6 0 0
2009 4 0 0
2010 7 0 0
2011 19 0 0
2012 54 1 0
2013 857 0 0
2014 210 0 1

View full timeline →

What Is DAYTRANA Used For?

IndicationReports
Attention deficit/hyperactivity disorder 1,139
Product used for unknown indication 265
Autism 13
Disturbance in attention 8
Psychomotor hyperactivity 5

DAYTRANA vs Alternatives: Which Is Safer?

DAYTRANA vs DECITABINE DAYTRANA vs DEFERASIROX DAYTRANA vs DEFERIPRONE DAYTRANA vs DEFEROXAMINE DAYTRANA vs DEFIBROTIDE DAYTRANA vs DEFLAZACORT DAYTRANA vs DEGARELIX DAYTRANA vs DELAFLOXACIN MEGLUMINE DAYTRANA vs DELAMANID DAYTRANA vs DELANDISTROGENE MOXEPARVOVEC-ROKL

Official FDA Label for DAYTRANA

Official prescribing information from the FDA-approved drug label.